Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Nearly 70% of prior HBV vaccine nonresponders produced adequate antibodies after successful HCV treatment.
Vaccines are tested for safety, but like all medical products, they can sometimes cause side effects.
NIAID-supported research sheds light on why healthy people of the same age respond differently to vaccines.
Nearly all HIV-positive study participants achieved protective antibody levels after two doses of Heplisav-B.
Only 30% of U.S. adults have been vaccinated against the liver disease. Here’s how the Hepatitis B Foundation aims to change that.
The PreHevbrio vaccine produces higher antibody levels and offers faster protection.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.